$169 Million is the total value of Vantage Consulting Group Inc's 212 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SLQT | Exit | SelectQuote Inc | $0 | – | -15,899 | -100.0% | -0.01% | – |
| DHC | Exit | Diversified Healthcare Trust | $0 | – | -14,211 | -100.0% | -0.01% | – |
| CYH | Exit | Community Health Systems | $0 | – | -18,484 | -100.0% | -0.02% | – |
| DBD | Exit | Diebold Nixdorf Incorporated | $0 | – | -17,343 | -100.0% | -0.02% | – |
| GNW | Exit | Genworth Financial Inc Class A | $0 | – | -12,975 | -100.0% | -0.03% | – |
| SPNT | Exit | Sirius Point Ltd | $0 | – | -12,099 | -100.0% | -0.04% | – |
| LL | Exit | Lumber Liquidators Holdings In | $0 | – | -10,128 | -100.0% | -0.04% | – |
| KEYS | Exit | KEYSIGHT TECHNOLOGIES INC | $0 | – | -1,272 | -100.0% | -0.12% | – |
| RE | Exit | Everest Re Group Ltd. | $0 | – | -771 | -100.0% | -0.12% | – |
| TRV | Exit | Travelers Companies Inc | $0 | – | -1,334 | -100.0% | -0.12% | – |
| CB | Exit | Chubb Limited | $0 | – | -1,118 | -100.0% | -0.12% | – |
| WRB | Exit | BERKLEY (W R) CORP | $0 | – | -3,226 | -100.0% | -0.12% | – |
| GLW | Exit | Corning Inc | $0 | – | -8,115 | -100.0% | -0.14% | – |
| TEL | Exit | TE Connectivity Ltd. | $0 | – | -2,116 | -100.0% | -0.14% | – |
| DVN | Exit | Devon Energy Corporation | $0 | – | -3,984 | -100.0% | -0.14% | – |
| COG | Exit | CABOT OIL & GAS CORP | $0 | – | -9,167 | -100.0% | -0.14% | – |
| APH | Exit | AMPHENOL CORPcl a | $0 | – | -3,600 | -100.0% | -0.14% | – |
| TSLA | Exit | TESLA INC | $0 | – | -907 | -100.0% | -0.14% | – |
| CTXS | Exit | Citrix Systems Inc | $0 | – | -2,343 | -100.0% | -0.14% | – |
| PCG | Exit | PG&E CORP | $0 | – | -19,880 | -100.0% | -0.14% | – |
| TWTR | Exit | Twitter Inc | $0 | – | -8,628 | -100.0% | -0.22% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ROYALTY PHARMA PLC | 12 | Q3 2023 | 87.5% |
| ADC THERAPEUTICS SA SHS | 12 | Q3 2023 | 9.8% |
| FIBROGEN INC | 12 | Q3 2023 | 5.7% |
| COSTCO WHSL CORP NEW | 12 | Q3 2023 | 0.5% |
| WALMART INC | 12 | Q3 2023 | 0.5% |
| Sysco Corporation | 12 | Q3 2023 | 0.5% |
| Exxon Mobil Corporation | 12 | Q3 2023 | 0.5% |
| Chevron Corporation | 12 | Q3 2023 | 0.5% |
| KROGER CO | 12 | Q3 2023 | 0.5% |
| CVS Health Corporation | 12 | Q3 2023 | 0.5% |
View Vantage Consulting Group Inc's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SYNTAX ETF TRUST | September 11, 2023 | 717,132 | 52.2% |
| SYNTAX ETF TRUST | November 08, 2022 | 156,133 | 56.8% |
| SYNTAX ETF TRUSTSold out | June 24, 2021 | 0 | 12.4% |
View Vantage Consulting Group Inc's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13G/A | 2023-09-11 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-10 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| SC 13G/A | 2022-11-08 |
| SC 13G/A | 2022-10-04 |
View Vantage Consulting Group Inc's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.